Bluechiip Limited Stock Market Press Releases and Company Profile
Capital Raising Presentation
Capital Raising Presentation

Melbourne, Aug 15, 2016 AEST (ABN Newswire) - Bluechiip Ltd (googlechartASX:BCT) are pleased to provide the Company's latest presentation, 'Capital Raising and 1-for-3 Non-renounceable Rights Issue August 2016'. Bluechiip provides unique patented technology combining secure wireless tracking with integrated temperature sensing for extreme environments.

Investment Highlights

- Unique patented technology combining secure wireless tracking with integrated temperature sensing for extreme environments

- $2b+ bio-preservation/bio-storage target market

- Executed supply agreement with Genea Biomedx in the high value IVF market with global distribution through a major pharmaceuticals company

- Repeat initial revenue from license fees, service and product sales (2nd half FY16 $150k);

- Pipeline of over 15 partners with initial revenue from developer kits and validation customers

- High revenue growth expected in short to medium term on IVF product release early 2017

- Trial and developer agreements in protein crystallography, cell therapies, general biobanking and Auto Identification and Data Capture markets

- Government co-funded projects with University of Melbourne & Swinburne University to make Bluechiips adaptable and suitable for formats with significant value enhancement

- Large adjacent market opportunities

To view the full presentation, please visit:
http://abnnewswire.net/lnk/EL2137FE


About Bluechiip Limited

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

https://twitter.com/bluechiip https://www.youtube.com/channel/UCaVcyO4O2oJ_9fLdMs6JIyQ https://www.linkedin.com/company/bluechiip-limited abnnewswire.com 


Contact

Corporate enquiries
Andrew McLellan
Managing Director - CEO
Ph: +61-457-823-470
andrew.mclellan@bluechiip.com

Media
Richard Allen
Ph: +61-3-9915-6341
Oxygen Financial PR
richard@oxygenpr.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 2) (Last 30 Days: 19) (Since Published: 2480)